Measurement of the Glial Fibrillary Acidic Protein and Its Breakdown Products GFAP-BDP Biomarker for the Detection of Traumatic Brain Injury Compared to Computed Tomography and Magnetic Resonance Imaging

Glial fibrillary acidic protein and its breakdown products (GFAP-BDP) are brain-specific proteins released into serum as part of the pathophysiological response after traumatic brain injury (TBI). We performed a multi-center trial to validate and characterize the use of GFAP-BDP levels in the diagno...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:J Neurotrauma
Main Authors: McMahon, Paul J., Panczykowski, David M., Yue, John K., Puccio, Ava M., Inoue, Tomoo, Sorani, Marco D., Lingsma, Hester F., Maas, Andrew I.R., Valadka, Alex B., Yuh, Esther L., Mukherjee, Pratik, Manley, Geoffrey T., Okonkwo, David O., Casey, Scott S., Cheong, Maxwell, Cooper, Shelly R., Dams-O'Connor, Kristen, Gordon, Wayne A., Hricik, Allison J., Lawless, Kerri, Menon, David, Schnyer, David M., Vassar, Mary J.
פורמט: Artigo
שפה:Inglês
יצא לאור: Mary Ann Liebert, Inc. 2015
נושאים:
Original Articles
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4394160/
https://ncbi.nlm.nih.gov/pubmed/25264814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/neu.2014.3635
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים